Affordable Access

deepdyve-link
Publisher Website

Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.

Authors
  • van Leeuwen, Pim J1, 2
  • Emmett, Louise3, 4
  • Ho, Bao3
  • Delprado, Warick5
  • Ting, Francis1, 2
  • Nguyen, Quoc2
  • Stricker, Phillip D1, 2
  • 1 St Vincent's Prostate Cancer Centre, St Vincent's Clinic, Sydney, NSW, Australia. , (Australia)
  • 2 Australian Prostate Cancer Research Centre, New South Wales, The Garvan Institute of Medical Research/The Kinghorn Cancer Centre, Sydney, NSW, Australia. , (Australia)
  • 3 Department of Diagnostic Imaging, St Vincent's Public Hospital, Sydney, NSW, Australia. , (Australia)
  • 4 University of New South Wales, Sydney, NSW, Australia. , (Australia)
  • 5 University of Notre Dame, Darlinghurst, NSW, Australia. , (Australia)
Type
Published Article
Journal
British Journal of Urology
Publisher
Wiley (Blackwell Publishing)
Publication Date
Feb 01, 2017
Volume
119
Issue
2
Pages
209–215
Identifiers
DOI: 10.1111/bju.13540
PMID: 27207581
Source
Medline
Keywords
License
Unknown

Abstract

In patients with intermediate- to high-risk PCa, 68Ga-PSMA PET/CT had a high specificity and a moderate sensitivity for LNM detection. 68Ga-PSMA PET/CT had the potential to replace current imaging for LN staging of patients with PCa scheduled for RP.

Report this publication

Statistics

Seen <100 times